Company: STAA
Filing Date: 2025-12-19
Form Type: DFAN14A
Source: 0001213900-25-123935
Chunk: 2

Company: STAAR SURGICAL CO
Filing Date: 2025-12-19
Form: DFAN14A
Chunk 2
---
 the Company
may contest, or otherwise challenge, the Participants’ ability to call the Stockholder Meeting. STOCKHOLDERS OF THE COMPANY ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE PARTICIPANTS WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION, INCLUDING ABOUT THE MATTERS TO BE VOTED ON AT THE STOCKHOLDER MEETING AND ADDITIONAL INFORMATION RELATING TO THE PARTICIPANTS AND THEIR DIRECT OR INDIRECT INTERESTS, BY SECURITY HOLDINGS OR OTHERWISE. The definitive proxy statement and an accompanying GREEN Proxy Card will be furnished to some
or all of the Company’s stockholders and will be, along with other relevant documents, available at no charge on the SEC’s
website at https://www.sec.gov/.

Information about the Participants and a description
of their direct or indirect interests, by security holdings or otherwise, is contained on an amendment to Schedule 13D filed by the Participants
with the SEC on December 17, 2025, and is available here.

<div align='center'>1</div>

Exhibit 1

<div align='center'>Broadwood Partners Denounces STAAR Surgical’s Fourth Delay of the Shareholder Vote on the Company’s Proposed Sale to Alcon

Urges Board to Allow Shareholders to Have Their Final Say on This Ill-Conceived Transaction</div>

New York – (BUSINESS WIRE) – Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which
together own 30.2% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ:
STAA), today responded to the fourth postponement of STAAR’s Special Meeting of Shareholders (the “Special Meeting”)
in connection with the proposed acquisition of STAAR by Alcon Inc. (“Alcon”) (NYSE: ALC).

The Special Meeting, which was originally scheduled
to be held on October 23, 2025, was adjourned in the face of then-pending rejection, rescheduled (following two subsequent postponements)
to be held on December 19, 2025. And today – seemingly in the face of yet another strong shareholder rebuke of the deal –
it was postponed yet again, until January 6, 2026.

Neal C. Bradsher, Broadwood Founder and President,
said: